PCR203 The Clinical and Financial Impact of GLP-1 Receptor Agonist and SGLT-2 Inhibitor Use in Type 2 Diabetes Management of Blue Cross and Blue Shield of Louisiana Members
Abstract
Authors
T. Vandergrift M. Liu B. Mohundro C. Allen J. Ouyang B. Vicidomina S. Nigam